Board of Directors


Caleb B. Bell III PhD

Caleb is a passionate entrepreneur who believes that people are the most valuable asset.  He is currently a co-Founder, Partner and CEO for G4S Capital and Ikigai Accelerator.  Previously, together with his brother, he founded Bell Biosystems, Inc. a synthetic biology company developing enabling tools for tracking and controlling cell therapies, where he served as CEO from inception to mid-2017.  Under his leadership, Bell Bio received ~$10M in financing from luminary investors, millions in grant funding from NIH and Breakout Labs, and garnered international recognition, including identification by the White House in 2014 as a “breakthrough life science technologies.”  Prior to that, Caleb started and managed multiple companies across diverse sectors including the hospitality, entertainment and drone industries.  Caleb received a B.S. in Biochemistry and Molecular Biology from the Pennsylvania State University, a Ph.D. in Biophysical Chemistry from Stanford University and business training through Stanford’s Graduate School of Business’ Ignite Program.  He is an inventor on more than 20 patents, author of over 25 peer-reviewed publications and text books. Caleb’s scientific interests include synthetic biology, biological magnetism, cell therapy and leveraging biologic systems to solve complex problems that improve human health and the environment